PT  - JOURNAL ARTICLE
AU  - Alexei Vazquez
TI  - Transition to multi-type mixing in d-dimensional spreading dynamics
AID  - 10.1101/2020.11.24.20238337
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.11.24.20238337
4099  - http://medrxiv.org/content/early/2021/01/25/2020.11.24.20238337.short
4100  - http://medrxiv.org/content/early/2021/01/25/2020.11.24.20238337.full
AB  - The spreading dynamics of infectious diseases is determined by the interplay between geography and population mixing. There is homogeneous mixing at the local level and human mobility between distant populations. Here I model spatial location as a type and the population mixing by intra- and inter-type mixing patterns. Using the theory of multi-type branching process, I calculate the expected number of new infections as a function of time. In 1-dimension the analysis is reduced to the eigenvalue problem of a tridiagonal Teoplitz matrix. In d-dimensions I take advantage of the graph cartesian product to construct the eigenvalues and eigenvectors from the eigenvalue problem in 1-dimension. Using numerical simulations I uncover a transition from linear to multi-type mixing exponential growth with increasing the population size. Given that most countries are characterized by a network of cities with more than 100,000 habitants, I conclude that the multi-type mixing approximation should be the prevailing scenario.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data have been reported in the manuscript.